Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
Stock Information for Vistagen Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.